Physician profile
David L Coven
NPI 1013941384
$1,091.10
in general payments reported to CMS, 2019-2025
13 companies · $425 in 2025
The $425 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.65 · 2020: $100 · 2021: $125 · 2022: $160 · 2023: $136 · 2024: $124 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $685.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $684.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $278.65 | 2021-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Penumbra, INC. | $245.78 | 2019-2025 | Indigo System |
| Abbott Laboratories | $123.71 | 2024 | Optis |
| Shockwave Medical, INC | $120.65 | 2025 | |
| Boston Scientific Corporation | $79.01 | 2025 | General - Therapies |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $64.41 | 2021-2022 | |
| Teleflex LLC | $55.23 | 2020 | |
| Pfizer INC. | $42.21 | 2022 | |
| Janssen Pharmaceuticals, INC | $25.83 | 2020 | |
| Terumo Medical Corporation | $19.35 | 2021 | |
| Cardiovascular Systems INC. | $19.13 | 2020 | |
| Medtronic, INC. | $17.14 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Coven listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.